ES2136680T3 - Envases con gas comprimido con empleo de esteres de acidos grasos de polioxietilen-glicerilo como estabilizadores de suspensiones y lubricantes para valvulas. - Google Patents

Envases con gas comprimido con empleo de esteres de acidos grasos de polioxietilen-glicerilo como estabilizadores de suspensiones y lubricantes para valvulas.

Info

Publication number
ES2136680T3
ES2136680T3 ES94107874T ES94107874T ES2136680T3 ES 2136680 T3 ES2136680 T3 ES 2136680T3 ES 94107874 T ES94107874 T ES 94107874T ES 94107874 T ES94107874 T ES 94107874T ES 2136680 T3 ES2136680 T3 ES 2136680T3
Authority
ES
Spain
Prior art keywords
fatty acid
acid esters
compressed gas
gas containers
glyceryl fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94107874T
Other languages
English (en)
Inventor
Helmut Dr Hettche
Reinhard Dr Muckenschnabel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2136680T3 publication Critical patent/ES2136680T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Abstract

SE DESCRIBEN ENVASES DE GAS A PRESION DE AEROSOL PARA EMPOBRECIMIENTO DE SUSTANCIAS ACTIVAS BIOLOGICAS CON NUEVOS ESTABILIZADORES DE SUSPENSION Y AGENTES DE IMPULSION QUE NO DAÑAN EL OZONO.
ES94107874T 1993-07-08 1994-05-21 Envases con gas comprimido con empleo de esteres de acidos grasos de polioxietilen-glicerilo como estabilizadores de suspensiones y lubricantes para valvulas. Expired - Lifetime ES2136680T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4322703A DE4322703A1 (de) 1993-07-08 1993-07-08 Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel

Publications (1)

Publication Number Publication Date
ES2136680T3 true ES2136680T3 (es) 1999-12-01

Family

ID=6492224

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94107874T Expired - Lifetime ES2136680T3 (es) 1993-07-08 1994-05-21 Envases con gas comprimido con empleo de esteres de acidos grasos de polioxietilen-glicerilo como estabilizadores de suspensiones y lubricantes para valvulas.

Country Status (8)

Country Link
US (1) US5536444A (es)
EP (1) EP0633019B1 (es)
JP (1) JP3541060B2 (es)
AT (1) ATE183077T1 (es)
DE (2) DE4322703A1 (es)
DK (1) DK0633019T3 (es)
ES (1) ES2136680T3 (es)
GR (1) GR3031782T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840213A (en) * 1995-04-28 1998-11-24 Great Lakes Chemical Corporation Uses of heptafluoropropane
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
GB9620187D0 (en) * 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6660715B2 (en) 1998-11-19 2003-12-09 Massachusetts Institute Of Technology Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
US6432383B1 (en) 2000-03-30 2002-08-13 Generex Pharmaceuticals Incorporated Method for administering insulin
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US7255102B2 (en) * 2002-02-01 2007-08-14 Generex Pharmaceuticals Inc. Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US6979668B2 (en) * 2002-12-16 2005-12-27 Generex Pharmaceuticals Incorporated Cleaning compound for and method of cleaning valves and actuators of metered dose dispensers containing pharmaceutical compositions
ES2259915B1 (es) * 2005-03-15 2007-12-16 Laboratorio Aldo-Union, S.A. Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.
GB0614621D0 (en) * 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
JP4834803B2 (ja) 2006-09-14 2011-12-14 ランズバーグ・インダストリー株式会社 噴霧装置の製造方法
GB0620700D0 (en) * 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970584A (en) * 1973-02-14 1976-07-20 S. C. Johnson & Son, Inc. Aerosol package containing a foam-forming emulsion and propellent system
US4350605A (en) * 1977-11-22 1982-09-21 Peterson/Puritan, Inc. Water-in-oil emulsions
SU1082789A1 (ru) * 1982-03-24 1984-03-30 Рижское Ордена Ленина Производственное Объединение "Вэф" Им.В.И.Ленина Аэрозольный состав
JPS59217784A (ja) * 1983-05-20 1984-12-07 Toyo Aerosol Kogyo Kk エアゾ−ル懸濁剤
SU1297860A1 (ru) * 1983-08-17 1987-03-23 Н.Н.Оборин Способ послеоперационной профилактики абдоминальной спаечной болезни
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
JP2573275B2 (ja) * 1986-03-10 1997-01-22 ブルグハルト，クルト 薬学的製剤及びその製造法
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
US5156833A (en) 1990-02-07 1992-10-20 Lion Corporation Powder aerosol composition
US5091111A (en) * 1990-09-19 1992-02-25 S. C. Johnson & Son, Inc. Aqueous emulsion and aersol delivery system using same
ATE134509T1 (de) * 1991-06-10 1996-03-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
EP1277467B1 (en) * 1991-06-10 2006-09-20 Schering Corporation Non-chlorofluorocarbon aerosol formulations
CA2122272A1 (en) * 1991-11-22 1993-05-27 Susan C. Wivell Combined personal cleansing and moisturizing compositions
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
DE4305078A1 (en) * 1992-03-17 1993-09-23 Asta Medica Ag Pharmaceutical compsns. for inhalation contg. flezelastin or salts

Also Published As

Publication number Publication date
EP0633019B1 (de) 1999-08-11
DE59408608D1 (de) 1999-09-16
US5536444A (en) 1996-07-16
GR3031782T3 (en) 2000-02-29
JPH0770557A (ja) 1995-03-14
DK0633019T3 (da) 2000-03-20
ATE183077T1 (de) 1999-08-15
DE4322703A1 (de) 1995-01-12
JP3541060B2 (ja) 2004-07-07
EP0633019A1 (de) 1995-01-11

Similar Documents

Publication Publication Date Title
ES2136680T3 (es) Envases con gas comprimido con empleo de esteres de acidos grasos de polioxietilen-glicerilo como estabilizadores de suspensiones y lubricantes para valvulas.
ES2039929T3 (es) Procedimiento para la preparacion de liposomas y/o celulas biologicas que contienen sustancias constitutivas, asi como su aplicacion.
KR950700723A (ko) 폴리옥시에틸렌 글리세릴 올레에이트를 사용하는 압축가스 팩키징(Pressurized gas packagings using polyoxyethylene glyceryl oleates)
DE59409200D1 (de) Pharmazeutisches Präparat enthaltend Glucosidase- und/oder Amylasehemmer und einen Lipasehemmer
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
NO990454L (no) Aerosol-materiale
ES2176355T3 (es) Formulaciones de aerosol de peptidos y proteinas.
GR3031044T3 (en) Pharmaceutical and/or cosmetic preparation and the use of the preparation
DK0658101T3 (da) Aerosolformuleringer fri for overfladeaktivt middel og indeholdende beclomethasondipropionat
DE69225454D1 (de) Bacillus Bakterium und dessen Verwendung
RS49602B (sr) Farmaceutske mikrosfere valproinske kiseline za oralnu upotrebu
IL86395A (en) Pharmaceutical compositions with improved bioavailability containing flunarizine and polyethoxylated castor oil
DK0415902T3 (da) Oxy- eller thiosubstituerede fedtsyreanaloger til anvendelse ved behandling af retrovirale infektioner
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
MX9301410A (es) Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines.
GR3022503T3 (en) Pharmaceutical compositions for use as mast cell stabilizer
AU4628193A (en) Use of a direct-acting thrombin inhibitor for the manufacture of a medicinal product having thrombolytic activity
ES2054029T3 (es) Formulacion de acetato de flecainida con liberacion controlada.
ATE328980T1 (de) Treibgasmischung und diese enthaltende nahrungsmitteln in aerosolform
MX9306214A (es) Composicion novedosa y proceso para prepararla.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 633019

Country of ref document: ES